TRIPHASIC PROGRESSIVE [GENTECH™]

Reset your hairline, with the Triphasic Progressive Anti-Hairloss protocol.

Discover the 1st anti-hair loss treatment* targeting the 3 genetic markers responsible for hormonal & hereditary hair loss for an hairline reset and an extended hair longevity

*At René Furterer

RF_TRIPHASIC-PROGRESSIVE-GENTECH_DUO-LASER_2026

ULTIMATE HAIRLOSS PROTOCOL

INNOVATION TRIPHASIC PROGRESSIVE ANTI-HAIRLOSS

A complete protocol, clinically proven and dermatologically tested, for unparalleled results.

Stimulate the scalp and strengthen the hair fiber to promote stronger roots and prolong hair longevity.
Enjoy stronger, more resistant, and denser hair, and a less visible scalp. 

RF_TRIPHASIC-PROGRESSIVE-GENTECH_PACKSHOT-RANGE_2026

    Androgenetic alopecia, linked to genetic and hormonal factors, causes a shortening of the hair growth cycle. This hair loss manifests itself as a gradual loss of density and a receding hairline.

    After a decade of research, we have harnessed the power of three patented ingredients that block the three genetic markers responsible for this progressive hair loss.

    From the very first month, hair grows back strong, resistant, and thicker. In localized areas of hair loss, the scalp is less visible.*

    *Usage test on 69 people over 3 months, % perceived change. Hair grows back stronger (+66%), more resistant (+52%), and denser (+33%). In areas of localized hair loss, the scalp is less visible (81%).

    RF_GENTECH_AO-PUSH_2025_Woman_Serum-caps_Collection-ad-1_ 1x1_EN_RFGT10_3
    1. +2mm

      Hairline per cure¹

    2. +11 000

      Hair¹

    3. 100%

      Anti-hair loss efficacy²

    4. -52%

      Hairloss³

    ¹Average incrase of existing hair number in growth phase for men. Clinical study on 29 men and 32 women, results after 3 months of cure.

    ²Clinical study on 29 men, results after 3 months of cure.

    ³Clinical study on 30 people, results after 3 months of using the shampoo. 

    NEW [GENTECH™] TECHNOLOGY

    3 patented active ingredients
    targeting the 3 genetic markers responsible for hereditary & hormonal hair loss

    PATENTED¹ IRIS EXTRACT: [OR8D1] genetic marker target.
    Activates hair growth
    +33% extends hair life*

    PATENTED COPAIFERA EXTRACT: [PGD2s] genetic marker target.
    Ensures hair survival
    +146% promotes stronger anchorage**

    PATENTED GLYCERYL LAURATE : [DHTR] genetic market target.
    Preserves thicker hair bulb. Stops bulb miniaturization.


    ¹Patent-pending
    *Ex-vivo test on active ingredient
    **In-vitro test on active ingredient

    RF_TRIPHASIC_GENTECH_AO-PULL_Shampoo500ML_Carrousel_Eretail_product_3000x3000_ingredient_2025_NO-TEXT-psd

    FAQ

    Hair loss is a very common phenomenon: hair has a lifespan of 3 to 5 years and is renewed throughout life. Losing 50 to 100 hairs per day is therefore normal and should not cause concern, as they will quickly be replaced by new hair.
    The problem starts to become apparent when you lose more than 100 hairs per day. At this rate, they cannot be replaced quickly enough, which causes a reduction in hair mass.

    • Reactive hair loss, which, as its name suggests, occurs occasionally in response to an event (stress, illness, pregnancy, diet, fatigue, etc.), generally appearing two to three months after the event.
    • Progressive hair loss develops over several months and can gradually lead to baldness.
    They do not have the same causes and, therefore, are not treated in the same way. That is why René Furterer has developed two ranges of treatments, each targeting one of these types of hair loss.

    René Furterer anti-hair loss products can be used alone or in combination. The key to limiting hair loss, whatever the cause, is to create a new, more suitable hair care routine. It is therefore entirely possible to use products exclusively formulated for hair loss, such as oils, shampoo, masks, and serums. These products, with the exception of dietary supplements, can be used for a very long time without any adverse effects on the hair or health.